Actinium Pharmaceuticals, Inc (ATNM) Dividend History

Actinium Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing targeted cancer therapies using its proprietary Antibody-Radionuclide Conjugate (ARC) platform. The company specializes in creating treatments for hematologic malignancies and other cancers, leveraging its expertise in radiolabeled antibody technology to deliver targeted radiation directly to cancer cells.

Dividend History

Actinium Pharmaceuticals, Inc currently does not pay dividends

Company News

  • Rosen Law Firm is encouraging investors in Actinium Pharmaceuticals, Inc. (ATNM) who have lost more than $100,000 to seek legal counsel before the May 27 deadline for a securities class action lawsuit. The lawsuit alleges that the company made false and misleading statements about the likelihood of its Iomab-B drug candidate being approved by the FDA.

    GlobeNewswire Inc.
  • Here is how Actinium Pharmaceuticals (ATNM) and Encompass Health (EHC) have performed compared to their sector so far this year.

    Zacks Investment Research
    Featured Companies: EHC
  • Upgrades According to Morgan Stanley, the prior rating for First Solar Inc (NASDAQ:FSLR) was changed from Underweight to Equal-Weight. For the second quarter, First Solar had an EPS of $1.89, compared to year-ago quarter EPS of $0.52. At the moment, the stock has a 52-week-high of $232.00 and a 52-week-low of $115.66. First Solar closed at $186.48 at the end of the last trading period. For MP Materials Corp (NYSE:MP), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. MP Materials earned $0.09 in the second quarter, compared to $0.41 in the year-ago quarter. The stock has a 52-week-high of $36.67 and a 52-week-low of $19.18. At the end of the last trading period, MP Materials closed at $21.53. For MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI), Craig-Hallum upgraded the previous rating of Hold to Buy. MACOM Technology Solns earned $0.54 in the third quarter, compared to $0.73 in the year-ago quarter. The current stock performance of MACOM Technology Solns shows a 52-week-high of $85.42 and a 52-week-low of $48.53. Moreover, at the end of the last trading period, the closing price was at $81.04. For Cenovus Energy Inc (NYSE:CVE), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. In the second quarter, Cenovus Energy showed an EPS of $0.33, compared to $0.93 from the year-ago quarter. The stock has a 52-week-high of $22.17 and a 52-week-low of $14.45. At the end of the last trading period, Cenovus Energy closed at $20.20. B of A Securities upgraded the previous rating for CME Group Inc (NASDAQ:CME) from Underperform to Neutral. For the second quarter, CME Gr had an EPS of $2.30, compared to year-ago quarter EPS of $1.97. At the moment, the stock has a 52-week-high of $209.31 and a 52-week-low of $166.54. CME Gr closed at $202.53 at the end of the last trading period. For ResMed Inc (NYSE:RMD), Needham upgraded the previous rating of Hold to Buy. In the fourth quarter, ResMed showed an EPS of $1.60, compared to $1.49 from the year-ago quarter. The current stock performance of ResMed shows a 52-week-high of $243.52 and a 52-week-low of $152.26. Moreover, at the end of the last trading period, the closing price was at $153.89. Needham upgraded the previous rating for Semtech Corp (NASDAQ:SMTC) from Hold to Buy. For the first quarter, Semtech had an EPS of $0.02, compared to year-ago quarter EPS of $0.80. The current stock performance of Semtech shows a 52-week-high of $35.68 and a 52-week-low of $17.82. Moreover, at the end of the last trading period, the closing price was at $25.36. TD Cowen upgraded the previous rating for Constellation Brands Inc (NYSE:STZ) from Market Perform to Outperform. Constellation Brands earned $2.91 in the first quarter, compared to $2.66 in the year-ago quarter. The stock has a 52-week-high of $273.65 and a 52-week-low of $208.12. At the end of the last trading period, Constellation Brands closed at $257.50. According to Exane BNP Paribas, the prior rating for American Airlines Group Inc (NASDAQ:AAL) was changed from Neutral to Outperform. American Airlines Group earned $1.92 in the second quarter, compared to $0.76 in the year-ago quarter. The current stock performance of American Airlines Group shows a 52-week-high of $19.08 and a 52-week-low of $11.65. Moreover, at the end of the last trading period, the closing price was at $14.30. For Toast Inc (NYSE:TOST), UBS upgraded the previous rating of Neutral to Buy. In the second quarter, Toast showed an EPS of $0.19, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.00 and a 52-week-low of $15.77. Toast closed at $21.67 at the end of the last trading period. According to Baird, the prior rating for AeroVironment Inc (NASDAQ:AVAV) was changed from Neutral to Outperform. For the first quarter, AeroVironment had an EPS of $1.00, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $112.39 and a 52-week-low of $74.91. At the end of the last trading period, AeroVironment closed at $95.29. According to B of A Securities, the prior rating for Adecoagro SA (NYSE:AGRO) was changed from Underperform to Neutral. Adecoagro earned $0.40 in the second quarter, compared to $0.40 in the year-ago quarter. The stock has a 52-week-high of $11.75 and a 52-week-low of $6.96. At the end of the last trading period, Adecoagro closed at $11.55. According to Keybanc, the prior rating for Celanese Corp (NYSE:CE) was changed from Sector Weight to Overweight. For the second quarter, Celanese had an EPS of $2.17, compared to year-ago quarter EPS of $4.99. The current stock performance of Celanese shows a 52-week-high of $129.27 and a 52-week-low of $86.73. Moreover, at the end of the last trading period, the closing price was at $126.35. See all analyst ratings upgrades. Downgrades For Plains GP Holdings LP (NASDAQ:PAGP), Citigroup downgraded the previous rating of Buy to Neutral. In the second quarter, Plains GP Holdings showed an EPS of $0.25, compared to $0.30 from the year-ago quarter. The current stock performance of Plains GP Holdings shows a 52-week-high of $16.28 and a 52-week-low of $10.45. Moreover, at the end of the last trading period, the closing price was at $16.05. According to Longbow Research, the prior rating for Allegion PLC (NYSE:ALLE) was changed from Buy to Neutral. In the second quarter, Allegion showed an EPS of $1.76, compared to $1.37 from the year-ago quarter. The current stock performance of Allegion shows a 52-week-high of $128.36 and a 52-week-low of $87.73. Moreover, at the end of the last trading period, the closing price was at $111.14. According to Wells Fargo, the prior rating for Enbridge Inc (NYSE:ENB) was changed from Overweight to Equal-Weight. For the second quarter, Enbridge had an EPS of $0.51, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $43.03 and a 52-week-low of $33.96. ...Full story available on Benzinga.com

    Benzinga
Page data last updated 07/23/2025 09:36:08 UTC